N/A
N=177
Evaluation of a Multi-Purpose Solution
Contact Lens Solutions
Bottom Line
View on ClinicalTrials.gov: NCT00710879 ↗Enrolled (actual)
177
Serious AEs
0.0%
Results posted
Feb 2011
Primary outcome: Primary: Antimicrobial Efficacy — 114; 219; 0; 3 Eyes
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Bausch & Lomb Multi-Purpose Solution (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Bausch & Lomb Incorporated
- Primary completion
- Feb 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Antimicrobial Efficacy |
114; 219; 0; 3; 1; 4 | — |
| SECONDARY Solution Related AE's and Lens Changes |
118; 238; 2; 2; 0; 0 | — |
| SECONDARY Solution Utlility |
112; 225; 2; 5; 1; 4 | — |
Summary
This study evaluates a multi-purpose solution when used on a daily wear basis by currently adapted soft contact lens wearers.
Eligibility Criteria
Inclusion Criteria
- Is an adapted Group I or Group IV soft contact lens wearer and agrees to wear the study lenses on a daily wear basis.
- Must be able and willing to comply with all treatment and follow-up study procedures.
- Must have a clear central cornea.
- VA correctable to 0.3 LogMar or better (driving vision)
Exclusion Criteria
- Systemic disease affecting ocular health.
- Using systemic or topical medications.
- Wear monovision, multifocal or toric contact lenses.
- Any grade 2 or greater slit lamp findings.
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT00710879). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.